All Online

1 - 12 of 32 results

Refine

Active filters

Diabetes
Doctor talks to African American patient
1 CME CREDIT

Obesity & Diabetes: Patient-Centered Clinical Care of African Americans

Episode 3: Bridging the Gap: Conversations with Dr. Hall

1.00 CME

1. Review obesity and diabetes trends and health disparities in the US 2. Review body image and perception differences by race/ethnicity 3. Describe best practices in the treatment of diabetes in African Americans 4. Examine the difference in HbA1c interpretations in African Americans and related clinical considerations


0.25 CME CREDIT

A Brief Update of the Guidelines on the Management of Type 2 Diabetes - Frankly Speaking EP 155

Guest: Jill Terrien PhD, ANP-BCMusic Credit: Richard Onorato

0.25 CME

Join us as we discuss key points from the 2019 update to the American Diabetes Association and the European Association for the Study of Diabetes consensus report. This update is now reflected in the American Diabetes Association's Standards of Medical Care—2020.


0.25 CME CREDIT

Too Sweet! Rates of Prediabetes in US Adolescents and Young Adults - Frankly Speaking EP 161

Guest: Susan Feeney, DNP, FNP-BCMusic Credit: Richard Onorato

0.25 CME

The incidence and prevalence of prediabetes and Type II Diabetes Mellitus in adolescents and young adults has increased over the past decade. A recent cross-sectional study of 12 years of NHANES data suggests that this population has an associated increased cardiometabolic risk. Listen as our team discusses these findings and some prevention strategies to help improve health outcomes.


0.25 CME CREDIT

Putting the "Bite" on Type 2 Diabetes - Frankly Speaking EP 115

Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato

0.25 CME

In this episode we discuss how periodontal disease worsens A1C and other clinical outcomes in T2DM.


0.25 CME CREDIT

Saving Money on Insulin - Frankly Speaking EP 124

Guest: Alan M. Ehrlich, MD, FAAFPMusic Credit: Richard Onorato

0.25 CME

When patients with T2DM have difficulty controlling their glucose with standard approaches, or are newly diagnosed but severely hyperglycemic, insulin is commonly used to help control their metabolism. Using long acting, once a day agents is a standard of care but in the last 15 years, the costs of insulin has skyrocketed. During this episode we will review a study examining the effects of using Neutral Protamine Hagedorn Insulin (NPH) rather than once a day insulin on A1c control and risk for hypoglycemia and discuss their findings, which suggest NPH can be used with equivalent glycemic control and with no additional risk.


Coffee with Chopra: Episode 1
0.5 CME CREDIT

Advances in Diabetes and Reflections on Care

Episode 1: Coffee with Chopra

0.50 CME

Join Dr. Sanjiv Chopra, hepatologist, author, speaker, and thought leader as he interviews his guest, Dr. Martin Abrahamson, endocrinologist and associate professor at Harvard Medical School as they discuss major advances in diabetes as well as the promise of stem cell treatment, diet and weight loss in patients with diabetes, and advances in continuous glucose monitoring. The pair will end their conversation discussing what they have learned from patients over the years.


0.25 CME CREDIT

Listen to this podcast for a concise summary of the latest clinical practice guidelines for identifying glycemic targets and managing T2DM in various patient populations including, older adults, individuals with increased cardiac or renal risk, and those at risk for hypoglycemic events.


1 CME CREDIT

This talk will cover recent clinical trials presented at the ADA in 2019 that have an impact on the management of diabetes, such as cardiovascular outcomes trials and the first oral GLP-1 RA phase 3 data. The faculty will take you through the latest guidelines from the ADA regarding the management of type 2 diabetes and describe how recent clinical trial data has been integrated in to these guidelines. After this meeting review, you will be equipped to manage type 2 diabetes based on these guidelines. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020, and they are subject to change as new information is published.


1 CME CREDIT

This talk will cover recent clinical trials presented at the ADA in 2019 that have an impact on the management of diabetes, such as cardiovascular outcomes trials and the first oral GLP-1 RA phase 3 data. The faculty will take you through the latest guidelines from the ADA regarding the management of type 2 diabetes and describe how recent clinical trial data has been integrated in to these guidelines. After this meeting review, you will be equipped to manage type 2 diabetes based on these guidelines.


0.5 CME CREDIT

An elevated fasting blood glucose (FBG) is the hall mark of prediabetes. Fasting blood glucose increases approximately 1 mg/dl per year as a prediabetic. While it can take years for a person to develop type 2 diabetes from prediabetes, weight gain, sedentary lifestyle, illness, or stress, can accelerate this process. This presentation will discuss the prevalence and progression of prediabetes, as well as the most effective strategies to prevent the development of type 2 diabetes.


0.75 CME CREDIT

This talk will provide an opportunity for the learner to (anonymously) test his/her knowledge in the management of people with type 2 diabetes using cases and an ARS. The cases will also be used to illustrate the pathophysiology of type 2 diabetes and provide an opportunity for developing a practical approach to treating people with type 2 diabetes, utilizing the commonest and newest medications available. The cases will also help the learners use medications safely and understand advantages and disadvantages, and common side effects of each class of medication. Finally a practical approach to the initiation and intensification of basal insulin will be covered.


0.75 CME CREDIT

In this talk, the speaker will discuss goals of treatment as it relates to microvascular complication risk reduction and reasons for using insulin in specific populations, focusing on type 2 diabetes. Additionally, learners will review currently available short- and long-acting insulins on the U.S. market and associated risks and benefits of use. Finally, the speaker will expand on the practical use of insulin (i.e., when to start, how to titrate, etc.).